Millendo Therapeutics, Inc. MLND
$ 1.06
-5.36%
Millendo Therapeutics, Inc. Income Statement 2011-2024 | MLND
Annual Income Statement Millendo Therapeutics, Inc.
2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
2.5 M | 7.73 M | 1.06 M | 2.59 M | 3.26 M | 10.2 M | 65.6 M | 10.1 M | 3.26 M | - |
Shares |
1.27 M | 914 K | 103 K | 159 K | 143 K | 120 K | 101 K | 71.8 K | 25.8 K | - |
Net Income |
- | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - |
EBITDA |
- | - | - | - | - | - | - | - | - | - |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
- | - | - | - | - | - | - | - | - | - |
All numbers in USD currency